help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koshimizu, T.-a.
Right arrow Articles by Stojilkovic, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koshimizu, T.-a.
Right arrow Articles by Stojilkovic, S. S.
Endocrinology Vol. 141, No. 11 4091-4099
Copyright © 2000 by The Endocrine Society


ARTICLES

Characterization of Purinergic Receptors and Receptor-Channels Expressed in Anterior Pituitary Cells

Taka-aki Koshimizu, Melanija Tomic, Anderson On-Lam Wong, Dragoslava Zivadinovic and Stanko S. Stojilkovic

Endocrinology and Reproduction Research Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892-4510

Address all correspondence and requests for reprints to: Dr. Stanko Stojilkovic, Section on Cellular Signaling, ERRB/NICHD, Building 49, Room 6A-36, 49 Convent Drive, Bethesda, Maryland 20892-4510. E-mail: stankos{at}helix.nih.gov


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Purinergic G protein-coupled receptors (P2YR) and ion-conducting receptor-channels (P2XR) are present in the pituitary. However, their identification, expression within pituitary cell subpopulations, and the ability to elevate intracellular Ca2+ concentration ([Ca2+]i) in response to ATP stimulation were incompletely characterized. Here we show that mixed populations of rat anterior pituitary cells express messenger RNA transcripts for P2Y2R, P2X2aR, P2X2bR, P2X3R, P2X4R, and P2X7R. The transcripts and functional P2Y2R were identified in lactotrophs and GH3 cells, but not in somatotrophs and gonadotrophs, and their activation by ATP led to an extracellular Ca2+-independent rise in [Ca2+]i in about 40% of cells tested. Lactotrophs and GH3 cells, but not somatotrophs, also express transcripts for P2X7R, P2X3R, and P2X4R. Functional P2X7R were identified in 74% of lactotrophs, whereas 50% of these cells expressed P2X3R and 33% expressed P2X4R. Coexpression of these receptor subtypes in single lactotrophs was frequently observed. Purified somatotrophs expressed transcripts for P2X2aR and P2X2bR, and functional receptors were identified in somatotrophs and gonadotrophs, but not in lactotrophs. Consistent with the cell-specific expression of transcripts for P2X2R and P2X3R, the expression of their functional heteromers was not evident in pituitary cells. Receptors differed in their capacities to elevate and sustain Ca2+ influx-dependent rise in [Ca2+]i during the prolonged ATP stimulation. These results indicate that the purinergic system of anterior pituitary is extremely complex and provides an effective mechanism for generating a cell- and receptor-specific Ca2+ signaling pattern in response to a common agonist.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
PURINERGIC receptors are operative in a variety of tissues, including the pituitary gland (1). G protein-coupled adenosine receptors (ARs) and adenosine nucleo-tide-controlled receptors (P2YRs) and receptor-channels (P2XRs) are expressed in the pituitary. Adenosine 5'-triphosphate (ATP), the common and native agonist for all P2XRs and P2YRs, is secreted by anterior pituitary cells (2, 3) and the biological actions of ATP are terminated by ectonucleotidases (2). These enzymes degrade extracellular ATP in a sequential manner to adenosine, thereby activating ARs. The presence of phospholipase C-coupled P2YR was initially observed in a mixed population of sheep pituitary cells (4, 5). Single cell Ca2+ measurements have shown that activation of these receptors by ATP in rat pituitary cells is associated with an elevation in the intracellular Ca2+ concentrations ([Ca2+]i) derived from intracellular and extracellular sources (6, 7, 8). Molecular cloning and functional characterization of rat P2YRs in the pituitary revealed the presence of P2Y2R subtype with the pharmacological profile resembling the one observed in primary cultures of sheep pituitary cells (9). Pharmacological studies have also suggested the presence of P2XRs in pituitary cells (3, 10). The messenger RNAs (mRNAs) for P2X2aR and its spliced form, P2X2bR, in pituitary cells have been identified recently (11, 12). Cultured and immortalized pituitary cells also express A1-subtype of adenosine receptors, which are negatively coupled to adenylyl cyclase pathway. Receptor-mediated suppression of cAMP production together with the activation of inward rectifier potassium channels accounts for the inhibition of spontaneous electrical activity and PRL release (13, 14).

The presence of all three types of purinergic receptors in anterior pituitary is consistent with a view that ATP plays an important role in the control of Ca2+-signaling and secretion in anterior pituitary. However, it has not been clarified as to which subtypes of P2 receptors are expressed and operative in the pituitary, nor the cell specificity in the expression/coexpression of these receptors. The focus in this study is on expression, distribution, and Ca2+ signaling function of P2YRs and P2XRs within three major subpopulations of secretory anterior pituitary cells, including lactotrophs, gonadotrophs, and somatotrophs. We screened the expression of all eight known P2XRs in cultured and immortalized pituitary cells. To help with the identification of receptor subtypes within these pituitary cells, we also expressed the P2XRs in GT1 hypothalamic neurons, which have a set of plasma membrane channels highly comparable to that of anterior pituitary cells (15, 16), but do not express P2YRs and P2XRs (12). The pharmacological and Ca2+-signaling profiles of recombinant channels were compared with those observed in secretory anterior pituitary cells. The results of these investigations revealed an unusual complexity in the expression pattern and Ca2+-signaling functions of these receptors and channels in the pituitary, especially in the lactotrophs.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Cell cultures and transfection
Experiments were performed on anterior pituitary cells from adult female Sprague Dawley rats from Taconic Farms, Inc. (Germantown, NY), as well as on immortalized GH3 pituitary cells and GT1 hypothalamic neurons. Pituitary cells were dispersed as previously described (12) and cultured in medium 199 containing Earle’s salts, sodium bicarbonate, 10% horse serum, and antibiotics. GH3 and GT1 cells were cultured in DMEM medium containing 10% FCS (Life Technologies, Inc., Rockville, MD). Procedures for transient transfection in GT1 cells were performed as described (17) with minor modifications. Briefly, cells were plated on 35 mm coverslips coated with poly-L-lysine at a density of 7.5 x 104 cell per 35 mm dish and allowed to grow for 24 h. On the day of transfection, a total amount of 1.2 µg of expression constructs encoding P2XRs was mixed with 8 µl of cationic lipid Lipofectamine in a 1.2 ml of Opti-MEM medium (Life Technologies, Inc.), for 15 min at ambient temperature. The DNA mixture was then applied to cells for 3 h and replaced by normal culture medium. The cells were subjected to experiments 48 h after the transfection.

Cell purification
Separation of gonadotroph-, somatotroph-, and lactotroph-enriched populations was performed according to the size and density of pituitary cells, using the Eppendorf Cell Separation System. The one-liter disc-shaped chamber was filled from the bottom opening with about 900 ml of 2% to 4% Ficoll continuous gradient solution and then completed with 10% Ficoll solution. Dispersed cells (100 x 106) were suspended in 50 ml of 1% Ficoll solution and loaded into the chamber from the top opening. After adding 30 ml of separation medium on the top, the chamber was oriented to the horizontal position and was allowed to sediment at unit gravity for 2 h. The chamber was then reoriented to the inclined position and 15 fractions were collected from the bottom opening. Cells were washed, counted, and 105 cells from the unfractionated sample and from each separated fraction were suspended in 10 mM sodium carbonate, sonicated, and kept frozen at -20 C. Their hormonal contents were estimated by RIAs for rat LH, FSH, TSH, ACTH, PRL, and GH, which were done using the kits provided by Dr. Parlow and the National Hormone Pituitary Program. The highest concentrations of LH, TSH, GH, ACTH, and PRL were respectively found in fractions 1, 4, 8, 10, and 14. Estimated by the reverse hemolytic plaque assay, the percentage of purified cells was: 82% for LH-secreting cells, 68% for GH-secreting cells, and 85% for PRL-secreting cells. Purification of somatotrophs and lactotrophs was also done by a two-stage Percoll discontinuous density gradient centrifugation (18). Using the immunohistochemical staining approach, the purity of the enriched somatotroph and lactotroph fractions was estimated to be 92% and 64%, respectively.

Measurements of intracellular calcium ion concentration
For [Ca2+]i measurements, cells were incubated in Krebs-Ringer buffer, supplemented with 2 µM fura-2 AM, at 37 C for 60 min. Coverslips with cells were washed with this buffer and mounted on the stage of an Axiovert 135 microscope (Carl Zeiss, Oberkochen, Germany) attached to the Attofluor Digital Fluorescence Microscopy System (Atto Instruments, Rockville, MD). Cells were examined under a 40x oil immersion objective during exposure to alternating 340 and 380 nm light beams, and the intensity of light emission at 520 nm was measured. The ratio of light intensities, F340/F380, which reflects changes in Ca2+ concentration, was followed in several single cells simultaneously at room temperature.

RT-PCR analysis of purinergic receptors and channels
Total RNA was isolated from mixed pituitary cells, or enriched somatotrophs and lactotrophs using TRIZOL reagent (Life Technologies, Inc.). First strand complementary DNA (cDNA) was then synthesized using a Superscript preamplification system (Life Technologies, Inc.). After RT using Superscript II RT and removal of RNA templates by RNase H digestion, a 5 µl-aliquot of first strand cDNA was used in subsequent PCR reactions. Primers for the P2XRs used in experiments are described in Ref (19). The P2Y2 specific primers corresponded to the rat P2Y2R sequence: nucleotides 404 to 424 for the sense primer (5'-AACGGACGCTGAGCATCCAAG-3') and 1611 to 1631 for the antisense primer (5'-TGAACTGACACCTGACTGAGC-3'). PCR conditions consisted of an initial denaturation step of 2 min at 94 C, followed by 20–25 cycles of denaturation at 94 C for 1 min, annealing at 60 C for 1 min, and extension at 72 C for 2 min. All PCRs were concluded with a final extension step of 10 min at 72 C. PCR samples were then size-fractionated in 1% agarose gel and visualized with ethidium bromide staining. To check for the integrity of RNA preparation, RT-PCR of GAPDH was also conducted as an internal control using primers GAPDH.S (5'-GGCATCCTGGGCTACACTG-3') and GAPDH.AS (5'-TGAGGTCCACCACCCTGTT-3') according to the PCR conditions reported previously (20). In these experiments, plasmids with the coding sequence of P2YR or P2XR cDNAs were used as the positive control for the respective PCRs.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Distribution of P2YRs and P2XRs within the anterior pituitary cells
To characterize the distribution of P2YRs and P2XRs within the different cell types, ATP-induced [Ca2+]i responses were analyzed in enriched subpopulations of secretory anterior pituitary cells. As discussed in Materials and Methods, purification of cells by Ficoll gradient procedure leads to 15 fractions of cells. Measurements of hormone contents in these fractions revealed that the first 3 fractions predominantly contained LH, fractions 3–5 TSH, fractions 5–10 GH, fractions 8–11 ACTH, and fractions 11–15 PRL. As shown in Fig. 1Go, the rise in [Ca2+]i in response to GnRH was highly specific for gonadotrophs, as estimated by the parallelism between the profiles of GnRH responsive cells (B) and LH content in these cells (C), and by their inability to respond to TRH (E). On the other hand, there was a close correlation between PRL content profile (F) with that of TRH-responsive cells identified based on single cell Ca2+ measurements (E). The TSH-containing fractions 3–5 also responded to TRH (E). A small fraction of unidentified cells (1–2%) from fraction 9 responded to both TRH and GnRH (see also Ref. 21). Thus, these isolation procedures provide an effective system to enrich gonadotrophs and lactotrophs, to separate the TRH-sensitive thyrotrophs and lactotrophs, and to identify single gonadotrophs and lactotrophs with respect to GnRH- and TRH-induced [Ca2+]i responses.



View larger version (26K):
[in this window]
[in a new window]
 
Figure 1. Distribution of purinergic receptors and receptor-channels within the subpopulations of anterior pituitary cells. Dispersed cells were separated by Ficoll gradient into 15 fractions as described in Materials and Methods. A and B, Percentage of cells responding to ATP (A) and ATP + GnRH (B), both when bathed in Ca2+-containing medium. C, LH content in different fractions (normalized values). D and E, Percentage of cells responding to ATP (D) and TRH (E) when bathed in Ca2+- deficient medium. F, PRL content in different fractions (normalized values). In A, B, D, and E, number of cells analyzed for [Ca2+]i response per fraction varied between 25 and 62. In C and F, 105 cells were dialyzed immediately after separation to measure LH and PRL cell content.

 
In Ca2+-containing medium, 100 µM ATP increased [Ca2+]i in 50–90% of the cells in different fractions, suggesting that purinergic receptors are native to all subpopulations of cells (Fig. 1AGo). The majority of GnRH-responsive cells also responded to ATP when bathed in Ca2+-containing medium (B), and only 1–2% of these cells responded to ATP when bathed in Ca2+-deficient medium (D). In lactotroph fractions of pituitary cells, however, ATP elevated [Ca2+]i in about 40% of cells in Ca2+-deficient medium (D) and in 80–90% of cells in Ca2+-containing medium (A). A group of unidentified cells elutriated with somatotroph/corticotroph fractions also responded to ATP with an extracellular Ca2+-independent rise in [Ca2+]i (fractions 5–10). These results indicate that Ca2+-mobilizing P2YRs are predominantly expressed in lactotrophs, whereas all subpopulations of anterior pituitary cells expressed P2XRs capable of facilitating Ca2+ influx.

Characterization of pituitary P2YRs
The pharmacological profile of P2YRs expressed in lactotrophs is shown in Fig. 2Go. In addition to ATP, these receptors also responded to uridine triphosphate (UTP), a specific agonist for P2Y2R and P2Y4R, and adenosine-5'-O-(3-thio-triphosphate) (ATP-{gamma}-S) when bathed in Ca2+-deficient medium (Fig. 2AGo). The relative potency of ATP agonists for these receptors was ATP > UTP > ATP-{gamma}-S. We have also examined the effects of 3'-O-(4-benzoyl)benzoyl-ATP (BzATP), a relatively specific agonist for P2X7R (22), on [Ca2+]i response in lactotrophs bathed in Ca2+-deficient medium. As shown in Fig. 2AGo, BzATP was unable to initiate Ca2+ signaling in lactotrophs. Several other ATP analogs, including {alpha},ß-methylene ATP ({alpha},ß-meATP; Fig. 2AGo) and 2-methylthio-ATP (2-MeS-ATP; not shown) were also ineffective in generating Ca2+ signals in lactotrophs bathed in Ca2+-deficient medium. Such a pharmacological profile of [Ca2+]i responses was typical for all responding cells, suggesting that these cells express P2Y2R subtype. In accordance with the results of pharmacological characterization, RT-PCR using P2Y2R primers also detected a PCR fragment with the expected size of P2Y2R in enriched lactotrophs. This specific message was also identified in immortalized GH3 cells (Fig. 2BGo).



View larger version (32K):
[in this window]
[in a new window]
 
Figure 2. Characterization of P2YR expressed in lactotrophs. A, Pattern of [Ca2+]i response in purified lactotrophs. Arrows indicate the moment of agonist application. The final concentration of ATP and its analogs was 100 µM. At the end of each experiment, 100 nM TRH was added. Experiments were performed in Ca2+-deficient medium. About 40% of lactotrophs responded to ATP in such conditions. B, RT-PCR analysis of P2YR mRNA expression in enriched lactotrophs and GH3 cells (left panel). PCR was conducted using primers specific for rat P2Y2R. PCR products were then separated in 1% agarose gel and visualized with ethidium bromide. RT-PCR of glyceraldehyde phosphate dehydrogenase (GAPDH, right panel) was performed to monitor the quality of RNA preparation. Total RNA isolated from the rat brain was used as the positive control. In the case of "no template" control, water was substituted for the first strand cDNA sample in PCR reaction.

 
Expression of P2XR transcripts in anterior pituitary cells
Molecular identification of P2XRs expressed in anterior pituitary cells was also obtained by RT-PCR analysis. Using specific rat P2X2R primers, which covered the entire open reading frame of P2XR cDNA sequence, two sizes of PCR products of about 1.6 kb and 1.4 kb long were detected in mixed populations of pituitary cells (Fig. 3AGo, lane 1). As described in (12), these products corresponded to P2X2aR and its spliced form, P2X2bR, and their presence in the mixed population of pituitary cells was confirmed by specific primers. The mRNAs for these channels were observed in somatotrophs purified by two-stage Percoll discontinuous density gradient centrifugation (Fig. 3CGo, lane 2).



View larger version (37K):
[in this window]
[in a new window]
 
Figure 3. Expression of P2XRs in pituitary cells. A, Detection of P2XRs in mixed population of anterior pituitary cells (lane 1) and immortalized GH3 cells (lane 4). B, Expression of P2X3R, P2X4R, and P2X7R mRNA in enriched somatotrophs (lane 2) and lactotrophs (lane 4). C, Expression of P2X2R mRNA in enriched somatotrophs (lane 2). Plasmids containing the coding sequence of the respective P2XR cDNAs were used as positive controls (A, lanes 2 and 5; B and C, lane 1). For negative controls, PCR was conducted using first strand cDNA samples without RT (A, lanes 3 and 6; B, lanes 3 and 5; C, lane 3). In the case of "no template" control, water was substituted for first strand cDNA sample in PCR reactions (B, lane 6; C, lane 4). DNA markers are shown in lanes 7 and 8 (B) and 5 and 6 (C). Primer sequences are described in Ref. 19 . A 10 µl-aliquot of PCR products was analyzed in 1% agarose gel containing ethidium bromide. GAPDH primers were used as an internal control to monitor the quality of RNA preparation.

 
In addition to P2X2R transcripts, mixed anterior pituitary cells also expressed transcripts for P2X3R, P2X4R, and P2X7R (Fig. 3AGo, lane 1). Immortalized GH3 pituitary cells also expressed transcripts for P2X3R, P2X4R, and P2X7R, but not P2X2aR and P2X2bR (Fig. 3AGo, lane 4). In parallel to GH3 transcript profile, the messages for P2X3R, P2X4R, and P2X7R were found in purified lactotrophs (Fig. 3BGo, lane 4), but not in somatotrophs (lane 2). Finally, the transcripts for P2X1R, P2X5R, and P2X6R were not observed in mixed pituitary cells (Fig. 3AGo, lane 1) and GH3 cells (Fig. 3AGo, lane 4).

Calcium signaling by recombinant channels
To help identify functional P2XR subtypes present in anterior pituitary cells, the recombinant channels were expressed in GT1 neurons and their pharmacological and [Ca2+]i signaling profiles were compared with those observed in lactotrophs, somatotrophs, and gonadotrophs. As shown in Fig. 4Go, GT1 cells expressing homomeric P2X3R responded to {alpha}ß-methylene ATP ({alpha}ß-meATP) with a small amplitude and transient rise in [Ca2+]i. In accord with the literature data (19, 23, 24), the heteromeric P2X2R + P2X3R channels also responded to this agonist (Fig. 4AGo). However, the amplitude of {alpha}ß-meATP-induced [Ca2+]i responses in cells expressing P2X2R + P2X3R was higher compared with that observed in P2X3R-expressing cells (Fig. 4AGo vs. 4B). Cells expressing P2X2aR, P2X2bR, P2X4R, and P2X7R were insensitive to {alpha}ß-meATP (Fig. 4Go, C–F). These results indicate that {alpha}ß-meATP can be used in [Ca2+]i measurements, as in current measurements (23) as a highly selective agonist for the identification of functional P2X3R homomers and P2X2R + P2X3R heteromers.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 4. Effects of {alpha}, ß-meATP, the specific agonist for P2X3R, on Ca2+ influx in GT1 neurons transiently expressing the recombinant P2XRs. Cells were transfected with one of the P2XRs, or in combination (top trace) and were subjected to stimulation 48 h after the transfection. ATP was added in the presence of {alpha}, ß-meATP. The traces shown are representative from at least 20 records for each receptor.

 
Another agonist, 3'-O-(4-benzoyl)benzoyl-ATP (BzATP) was able to elevate [Ca2+]i in cells expressing P2X7R, P2X2aR, and P2X2bR, whereas P2X3R- and P2X4R-expressing cells were practically insensitive to this agonist (Fig. 5AGo). In P2X7R-expressing cells, addition of 100 µM ATP in the presence of 100 µM BzATP was ineffective (Fig. 5AGo, bottom trace), whereas in all P2X2aR and P2X2bR-expressing cells ATP was able to further elevate [Ca2+]i (two top traces). This suggests that P2X7R is more sensitive to BzATP, contrary to P2X2aR and P2X2bR, which are more sensitive to ATP. Consistent with this, BzATP induced an additional rise in [Ca2+]i in P2X7R-expressing cells already stimulated with ATP, 2-MeS-ATP, or ATP-{gamma}-S (Fig. 5BGo, right traces) but was ineffective in P2X2aR-expressing cells stimulated with these agonists (Fig. 5BGo, left traces). Such pharmacological profiles of P2X2R and P2X7R provide an effective tool to identify cells expressing these two channels.



View larger version (30K):
[in this window]
[in a new window]
 
Figure 5. Effects of BzATP on Ca2+ influx in GT1 neurons transiently expressing the recombinant P2XRs. A, Effects of BzATP and ATP on [Ca2+]i in cells expressing different P2XRs. ATP was added in the presence of BzATP. B, Comparison of the effects of BzATP vs. other ATP analogs on [Ca2+]i in cells expressing P2X2aR (left traces) and P2X7R (right traces).

 
The BzATP-insensitivity of P2X4R (Fig. 5AGo) is a useful but not sufficient tool in a search for cells expressing these channels. However, only two cloned channels, P2X4R and P2X6R, are insensitive to suramin, a P2XR antagonist (25). As shown in Fig. 6AGo, ATP-induced [Ca2+]i response in P2X4R-expressing cells was not affected by the addition of 200 µM suramin for 3 min before the application of ATP. Because the message for P2X6R was not observed in pituitary cells (Fig. 3Go), the insensitivity of P2X4R channels to suramin was employed in a search for their expression in pituitary cells.



View larger version (13K):
[in this window]
[in a new window]
 
Figure 6. Characterization of P2X4R in GT1 neurons and lactotrophs. A, Suramin-insensitivity of recombinant P2X4R expressed in GT1 neurons. The tracings shown are averaged data from 20 records. B, Suramin-insensitivity of ATP-induced [Ca2+]i response in a fraction of lactotrophs.

 
Characterization of P2XR expressed in pituitary cells
In a mixed population of anterior pituitary cells, {alpha}ß-meATP, the specific agonist for P2X3R and P2X2R + P2X3R, was able to induce rise in [Ca2+]i only in TRH-sensitive cells. A fraction of lactotrophs, but not gonadotrophs and somatotrophs, also responded to {alpha}ß-meATP with a rise in [Ca2+]i, the pattern of which was highly comparable to that observed in GT1 neurons expressing homomeric P2X3R (Fig. 7AGo vs. 4B). None of the {alpha}ß-meATP-sensitive cells generated [Ca2+]i signals with the amplitude and duration comparable to that observed in cells bearing heteromeric P2X2R + P2X3R. This is consistent with the absence of P2X2R transcripts in immortalized GH3 cells (Fig. 3AGo) and P2X3R transcripts in purified somatotrophs (Fig. 3BGo), further suggesting that lactotrophs only express P2X3R homomers. Table 1Go illustrates that about 50% of lactotrophs express these channels.



View larger version (33K):
[in this window]
[in a new window]
 
Figure 7. Pharmacological characterization of P2XR and P2YR in lactotrophs. A, Characterization of {alpha}, ß-meATP- sensitive P2X3R in lactotrophs. Top trace, Lactotroph responding to {alpha}, ß-meATP, the specific agonist for P2X3R, but not to ATP. Bottom traces, Cells responding to both {alpha}, ß-meATP and ATP or BzATP, which were added in the presence of {alpha}, ß-meATP. B, Characterization of P2X7R expressed in lactotrophs by comparing the potency of ATP and its analogs in promoting Ca2+ influx. C, Coexpression of BzATP-sensitive P2X7R and BzATP-insensitive P2Y2R in lactotrophs.

 

View this table:
[in this window]
[in a new window]
 
Table 1. Distribution of functional P2XRs in anterior pituitary cells

 
On the other hand, BzATP, an agonist that activates P2X7R and P2X2R, induced rises in [Ca2+]i in a majority of lactotrophs, somatotrophs, and gonadotrophs. About 75% of lactotrophs (Table 1Go) responded to BzATP with the nondesensitizing [Ca2+]i response, typically observed in P2X7R-expressing cells. Consistent with this conclusion, addition of ATP, ATP-{gamma}-S, and 2-MeS-ATP in the presence of BzATP was ineffective in all lactotrophs studied. Figure 7BGo illustrates three such cells. In contrast to lactotrophs, addition of ATP, ATP-{gamma}-S, and 2-MeS-ATP in the presence of BzATP, induced further increase in [Ca2+]i in somatotrophs and gonadotrophs (Fig. 8Go), indicating that these cells express P2X2R. In accordance with this, BzATP was unable to elevate [Ca2+]i in the presence of ATP, ATP-{gamma}-S, or 2-MeS-ATP (Fig. 8Go, right tracings). This pattern of response was observed in 84% of gonadotrophs, and 82% of somatotrophs (Table 1Go).



View larger version (39K):
[in this window]
[in a new window]
 
Figure 8. Pharmacological characterization of P2X2R expressed in somatotrophs (left traces) and gonadotrophs (right traces). In somatotrophs, the traces shown are typical of those observed in quiescent cells (top trace) and spontaneously active cells (three bottom tracings). Arrows at bottom illustrate the moment of drug application in all traces shown. In gonadotrophs, the majority (about 80%) of cells were quiescent, and tracings shown are representative from such cells.

 
Finally, in a fraction of lactotrophs (Table 1Go), 100 µM ATP induced suramin-insensitive [Ca2+]i response, the pattern of which was highly comparable to that observed in GT1 neurons expressing homomeric P2X4R. Figure 6BGo illustrates a cell responding to ATP in suramin-containing and -deficient medium. Such a pattern of [Ca2+]i response was observed in about 33% of lactotrophs (Table 1Go). These results indicate that somatotrophs and gonadotrophs exclusively express P2X2R, whereas lactotrophs express P2X3R, P2X4R, and P2X7R, in addition to already characterized P2Y2R (6).

The coexpression of P2XRs in single lactotrophs was frequently observed. A fraction of cells expressing the {alpha},ß-meATP-sensitive P2X3R, also responded to the application of BzATP and ATP with additional rise in [Ca2+]i, presumably by activating P2X7R (Fig. 7AGo, two bottom traces). Similarly, about 15% of lactotrophs responded to BzATP with a nondesensitizing response and ATP with a spike response, suggesting the expression of both P2X7R and P2Y2R in the same cells (Fig. 7CGo, upper trace). Consistent with this, removal of extracellular Ca2+ abolished BzATP-induced rise in [Ca2+]i and the subsequent addition of ATP in Ca2+-deficient medium generated a typical Ca2+-mobilizing spike response. Finally, ATP was able to induce a suramin-insensitive rise in [Ca2+]i in a small fraction of lactotrophs already stimulated with BzATP, the profile of which was comparable to that observed in GT1 neurons expressing P2X4R (not shown).

In addition to the variable agonist sensitivity, pituitary P2XRs also differed with respect to their peak amplitude [Ca2+]i responses and temporal response patterns. As shown in Table 2Go, the highest amplitude of [Ca2+]i response was observed in pituitary gonadotrophs and somatotrophs expressing P2X2R. The peak amplitudes generated by P2X7R in lactotrophs were somewhat smaller, whereas the peak amplitude of [Ca2+]i response in lactotrophs expressing P2X3R and P2X4R was about 40% of that observed in cells expressing P2X2R. The native receptors also desensitized with different rates: P2X3R > P2X4R > P2X2R > P2X7R (Table 2Go).


View this table:
[in this window]
[in a new window]
 
Table 2. Characterization of agonist-induced [Ca2+]i responses in pituitary cells

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Functional purinergic receptors and receptor-channels are present in all subpopulations of pituitary cells, indicating that ATP acts as a nonselective agonist in the control of pituitary functions (10). However, the identification of receptor subtypes expressed in the pituitary and the selectivity of their expression in individual secretory cell types were incompletely characterized. Here we have identified the P2XR and P2YR subtypes that are operative in anterior pituitary and have characterized their expression in three secretory cell types: gonadotrophs, somatotrophs, and lactotrophs. Our RT-PCR results indicate that mixed pituitary cells express mRNA transcripts for P2Y2R, P2X2aR, and P2X2bR. In addition to those transcripts that have been previously found in mixed pituitary cells (9, 12), we have also identified transcripts for P2X3R, P2X4R, and P2X7R. The transcripts for P2Y2R, P2X3R, P2X4R, and P2X7R were found in lactotrophs, but not in somatotrophs, which exclusively express transcripts for P2X2aR and P2X2bR. The RT-PCR analysis of P2XRs in gonadotrophs was inconclusive, probably because of the low number of cells obtained by our cell purification procedures. Consistent with the results of RT-PCR analysis, single cell [Ca2+]i measurements indicate that lactotrophs express functional P2Y2R, as well as P2X3R, P2X4R, and P2X7R, whereas somatotrophs express P2X2R. The extensive pharmacological characterization of P2XRs in gonadotrophs also indicates that these cells express exclusively P2X2R subtypes.

When activated, these receptor-channels generate [Ca2+]i signals of different amplitude and duration. P2X3R generates small amplitude [Ca2+]i signals, which desensitize within 1–2 min. In contrast, P2X7R generates high amplitude [Ca2+]i signals that do not desensitize during the prolonged agonist stimulation. P2X2Rs expressed in gonadotrophs and somatotrophs are able to generate high amplitude [Ca2+]i signals, but they desensitize gradually and lead to the attenuation of Ca2+ signals to about 10–20% of that observed at the beginning of stimulation. In general, such pattern of Ca2+ signals resembles those observed in GT1 neurons transiently expressing recombinant P2XRs. However, in the case of P2X7R, there are differences between the peak amplitude of [Ca2+]i responses in pituitary cells vs. that of GT1 cells when stimulated with BzATP, which may be result of overexpression of these channels in host cells. The recombinant P2X2aR also desensitizes incompletely in GT1 cells, but the time needed to reach the steady-state signaling is prolonged when compared with the native P2X2Rs expressed in pituitary cells. This suggests that the mechanism of controlling Ca2+ influx through P2X2R is different between pituitary cells and GT1 cells used in our expression studies.

The coexpression of P2X2R with P2X3R provides an effective mechanism to control Ca2+ influx through P2X2aR (23, 24). Although the transcripts for P2X3R are present in pituitary cells; however, several lines of evidence argue against the existence of P2X2aR + P2X3R heteromers in pituitary cells. Purified lactotrophs and immortalized GH3 cells expressed the transcripts for P2X3R, whereas the transcripts for P2X2aR and P2X2bR were identified in somatotrophs. In parallel to that, functional P2X3R was identified in lactotrophs, as well as in an unidentified cell type, but not in gonadotrophs and somatotrophs. Finally, none of the {alpha},ß-meATP-sensitive cells from mixed subpopulations exhibited the pattern of Ca2+ signals generated by the recombinant P2X2aR + P2X3R heteromers. The cell specific expression of P2X2R and P2X3R in anterior pituitary probably accounts for the lack of coexpression of such heteromers.

On the other hand, we (12) and others (26, 27) reported recently that the control of Ca2+ influx through P2X2R can be achieved by the coexpression of P2X2aR and P2X2bR. Depending on the assemble mode, such heteromers can desensitize with variable rates (12). The Ca2+-signaling profiles in pituitary cells expressing P2X2R also resemble that of GT1 cells cotransfected with equal amounts of transcripts for P2X2aR and P2X2bR. Thus, it is reasonable to speculate that the control of ATP-induced [Ca2+]i signals in gonadotrophs and somatotrophs is achieved by expressing P2X2aR + P2X2bR heteromers.

In contrast to P2X3R and P2X2R, the native pituitary P2X7R and its recombinant channels expressed in GT1 cells do not exhibit an obvious desensitization. In the majority of cell expressing P2X7R channels, ATP initially induces opening of a channel selective for cations, including Ca2+ (25). During the prolonged agonist stimulation, P2X7R opens large pores allowing permeation of larger molecules and permeabilization of cells (22, 28). This activation step is dependent on the presence of C-terminus of the receptor (22) and on the environmental temperature (29). The physiological significance of this action is still unknown. Because the increased permeability results in larger ion fluxes and leakage of small metabolites, it may cause cell swelling and vacuolization, leading to cell death by necrosis and/or apoptosis (reviewed in Ref. 25). However, whether and to what extent P2X7R is used in the control of cell death in lactotrophs is still premature to discuss.

In conclusion, the results of these investigations indicate that the specificity found in the Ca2+-signaling responses induced by a common agonist is achieved by the capacity of individual receptor subtypes to generate different amplitude and kinetic patterns of Ca2+ responses and by the selective expression of receptors within the pituitary cell subpopulations. The ATP signaling pathway in somatotrophs and gonadotrophs is relatively simple. The majority of these cells express P2X2aR and P2X2bR, and their coexpression provides an effective system for a rapid elevation in [Ca2+]i, which is followed by a sustained plateau Ca2+ response of a much smaller amplitude. We were unable to observe any other P2X receptor subtypes expressed in these cells. The most striking finding shown here is the complexity of purinergic signaling system of lactotrophs. These cells express three types of channels, P2X3R, P2X4R, and P2X7R, as well as the Ca2+-mobilizing P2Y2R. The identification of P2XRs expressed in thyrotrophs and corticotrophs requires further studies. Pituitary P2X receptors can provide a wide range of Ca2+ signaling patterns when expressed individually or in combination. In this regard, the pituitary cells may provide a model to study how multiple receptors when expressed in excitable cells may generate different signaling in response to the same endogenous ligand.


    Acknowledgments
 
We are thankful to Drs. Silvie Dufour, Mohamed A. Virmani, and Antonio Martinez-Fuentes for help in establishing the purification procedures for pituitary cells.

Received March 20, 2000.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Brake AJ, Julius D 1996 Signaling by extracellular nucleotides. Annu Rev Cell Dev Biol 12:519–541[CrossRef][Medline]
  2. Tomic M, Jobin RM, Vergara LA, Stojilkovic SS 1996 Expression of purinergic receptor channels and their role in calcium signaling and hormone release in pituitary gonadotrophs. J Biol Chem 271:21200–21208[Abstract/Free Full Text]
  3. Chen Z-P, Kratzmeier M, Levy A, McArdle CA, Poch A, Day A, Mukhopadhyay AK, Lightman SL 1995 Evidence for a role of pituitary ATP receptors in the regulation of pituitary function. Proc Natl Acad Sci USA 92:5219–5223[Abstract/Free Full Text]
  4. Van Der Merwe PA, Wakefield IK, Fine J, Millar RP, Davidson JS 1989 Extracellular adenosine triphosphate activates phospholipase C and mobilizes intracellular calcium in primary cultures of sheep anterior pituitary cells. FEBS Lett 243:333–336[CrossRef][Medline]
  5. Davidson JS, Wakefield IK, Sohnius U, Van Der Merwe PA, Millar RP 1990 A novel extracellular nucleotide receptor coupled to phosphoinositidase-C in pituitary cells. Endocrinology 126:80–87[Abstract]
  6. Carew MA, Wu M-L, Law GJ, Tseng Y-Z, Mason WT 1994 Extracellular ATP activates calcium entry and mobilization via P2XU-purinoceptors in rat lactotrophs. Cell Calcium 16:227–235[CrossRef][Medline]
  7. Chen Z-P, Levy A, McArdle CA, Lightman SL 1994 Pituitary ATP receptors: characterization and functional localization to gonadotropes. Endocrinology 135:1280–1284[Abstract]
  8. Chen Z-P, Kratzmeier M, Poch, Xu S, McArdle CA, Levy A, Mukhopadhyay AK, Lightman SL 1996 Effects of extracellular nucleotides in the pituitary: adenosine triphosphate receptor-mediated intracellular responses in gonadotrope-derived {alpha}T3–1 cells. Endocrinology 137:248–256[Abstract]
  9. Chen Z-P, Krull N, Xu L, Levy A, Lightman SL 1996 Molecular cloning and functional characterization of a rat pituitary G protein-coupled adenosine triphosphate (ATP) receptor. Endocrinology 137:1833–1840[Abstract]
  10. Villalobos C, Alonso-Torre SR, Nunez L, Garcia-Sancho J 1997 Functional ATP receptors in rat anterior pituitary cells. Am J Physiol 273:C1963–C1971
  11. Brake AJ, Wagenbach, MJ, Julius D 1994 New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 371:519–523[CrossRef][Medline]
  12. Koshimizu T, Tomic M., Van Goor F, Stojilkovic SS 1998 Functional role of alternative splicing in pituitary P2X2 receptor-channel activation and desensitization. Mol Endocrinol 12:901–913[Abstract/Free Full Text]
  13. Schettini G, Landolfi E, Meucci O, Florio T, Grimaldi M, Ventra C. Marino A 1990 Adenosine and its analogue (-)N6-R-phenyl-isopropyladenosine modulate anterior pituitary adenylate cyclase activity and prolactin secretion in the rat. J Mol Endocrinol 5:69–76[Abstract]
  14. Mollard P, Guerineau N, Chiavaroli C, Schlegel W, Cooper DM 1991 Adenosine A1 receptor-induced inhibition of Ca2+ transients linked to action potentials in clonal pituitary cells. Eur J Pharmacol 206:271–277[CrossRef][Medline]
  15. Van Goor F, Krsmanovic LZ, Catt KJ, Stojilkovic SS 1999 Control of action potential-driven calcium influx in GT1 neurons by the activation status of sodium and calcium channels. Mol Endocrinol 13:587–603[Abstract/Free Full Text]
  16. Van Goor F, Krsmanovic LZ, Catt KJ, Stojilkovic SS 1999 Coordinate regulation of gonadotropin-releasing hormone neruonal firing patterns by cytosolic calcium and store depletion. Proc Natl Acad Sci USA 96:4101–4106[Abstract/Free Full Text]
  17. Koshimizu T, Tomic M, Koshimizu M, Stojilkovic SS 1998 Identification of amino acid residues contributing to desensitization of the P2X2 receptor channel. J Biol Chem 273:12853–12857[Abstract/Free Full Text]
  18. Lussier BT, French MB, Moor BC, Kraicer J 1991 Free intracellular Ca2+ concentration ([Ca2+]i and growth hormone release from purified rat somatotrophs. Endocrinology 128:570–582[Abstract]
  19. Koshimizu T, Koshimizu M, Stojilkovic SS 1999 Contributions of the C-terminal domain to the control of P2X receptor desensitization. J Biol Chem 274:37651–37657[Abstract/Free Full Text]
  20. Fort P, Rech J, Vie A., Piechaczyk M, Bonnieu A, Jeanteur P, Blanchard J-M 1987 Regulation of c-fos gene expression in hamster fibroblast: initiation and elongation of transcription and mRNA degradation. Nucleic Acids Res 15:5657–5665[Abstract/Free Full Text]
  21. Villalobos C, Nunez L, Frawley LS, Garcia-Sancho J, Sanchez A 1997 Multi-responsiveness of single anterior pituitary cells to hypothalamic-releasing hormones: a cellular basis for paradoxical secretion. Proc Natl Acad Sci USA 94:14132–14137[Abstract/Free Full Text]
  22. Surprenant A, Rassendren F, Kawashima E, North RA, Buell G 1996 The cytosolic P2XZ receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272:735–738[Abstract]
  23. Lewis C, Neidhart S, Holy C, North RA, Buell G, Surprenant A 1995 Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature 377:432–435[CrossRef][Medline]
  24. Radford KM, Virginio C, Surprenant A, North A. Kawashima E 1997 Baculovirus expression provides direct evidence for heteromeric assembly of P2X2 and P2X3 receptors. J Neurosci 17:6529–6533[Abstract/Free Full Text]
  25. Ralevic V, Burnstock G 1998 Receptors for purines and pyrimidines. Pharmacol Rev 50:413–492[Abstract/Free Full Text]
  26. Brandle U, Spielmanns P, Osteroth R, Sim J, Surprenant A. Buell G, Ruppersberg JP, Plinkert PK, Zenner H-P, Glowatski E 1997 Desensitization of the P2X2 receptor controlled by alternative splicing. FEBS Lett 404:294–298[CrossRef][Medline]
  27. Simon J, Kidd EJ, Smith FM, Chessell IP, Murrel-Lagnado R, Humphry PPA, Barnard EA 1997 Localization and functional expression of splice variants of the P2X2 receptor. Mol Pharmacol 52:237–248[Abstract/Free Full Text]
  28. Rassendren F, Buell GN, Virginio C, Collo G, North A, Surprenant A 1997 The permeabilizing ATP receptor, P2X7. J Biol Chem 272:5482–5486[Abstract/Free Full Text]
  29. Nuttle LC, Dubyak GR 1994 Differential activation of cation channels and non-selective pores by macrophage P2Xz purinergic receptors expressed in Xenopus oocytes. J Biol Chem 269:13988–13996[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Physiol.Home page
H. W. Zemkova, I. Bjelobaba, M. Tomic, H. Zemkova, and S. S. Stojilkovic
Molecular, pharmacological and functional properties of GABAA receptors in anterior pituitary cells
J. Physiol., July 1, 2008; 586(13): 3097 - 3111.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. E. Gonzalez-Iglesias, T. Murano, S. Li, M. Tomic, and S. S. Stojilkovic
Dopamine Inhibits Basal Prolactin Release in Pituitary Lactotrophs through Pertussis Toxin-Sensitive and -Insensitive Signaling Pathways
Endocrinology, April 1, 2008; 149(4): 1470 - 1479.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
K. Tsaneva-Atanasova, A. Sherman, F. van Goor, and S. S. Stojilkovic
Mechanism of Spontaneous and Receptor-Controlled Electrical Activity in Pituitary Somatotrophs: Experiments and Theory
J Neurophysiol, July 1, 2007; 98(1): 131 - 144.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. Zemkova, A. Balik, Y. Jiang, K. Kretschmannova, and S. S. Stojilkovic
Roles of Purinergic P2X Receptors as Pacemaking Channels and Modulators of Calcium-Mobilizing Pathway in Pituitary Gonadotrophs
Mol. Endocrinol., June 1, 2006; 20(6): 1423 - 1436.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. A. Andric, D. Zivadinovic, A. E. Gonzalez-Iglesias, A. Lachowicz, M. Tomic, and S. S. Stojilkovic
Endothelin-induced, Long Lasting, and Ca2+ Influx-independent Blockade of Intrinsic Secretion in Pituitary Cells by Gz Subunits
J. Biol. Chem., July 22, 2005; 280(29): 26896 - 26903.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-L. He, A. E. Gonzalez-Iglesias, and S. S. Stojilkovic
Role of Nucleotide P2 Receptors in Calcium Signaling and Prolactin Release in Pituitary Lactotrophs
J. Biol. Chem., November 21, 2003; 278(47): 46270 - 46277.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M.-L. He, H. Zemkova, T.-a. Koshimizu, M. Tomic, and S. S. Stojilkovic
Intracellular calcium measurements as a method in studies on activity of purinergic P2X receptor channels
Am J Physiol Cell Physiol, August 1, 2003; 285(2): C467 - C479.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. A. Andric, A. E. Gonzalez-Iglesias, F. Van Goor, M. Tomic, and S. S. Stojilkovic
Nitric Oxide Inhibits Prolactin Secretion in Pituitary Cells Downstream of Voltage-Gated Calcium Influx
Endocrinology, July 1, 2003; 144(7): 2912 - 2921.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T.-a. Koshimizu, S. Ueno, A. Tanoue, N. Yanagihara, S. S. Stojilkovic, and G. Tsujimoto
Heteromultimerization Modulates P2X Receptor Functions through Participating Extracellular and C-terminal Subdomains
J. Biol. Chem., November 27, 2002; 277(49): 46891 - 46899.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Aga, C. J. Johnson, A. P. Hart, A. G. Guadarrama, M. Suresh, J. Svaren, P. J. Bertics, and B. J. Darien
Modulation of monocyte signaling and pore formation in response to agonists of the nucleotide receptor P2X7
J. Leukoc. Biol., July 1, 2002; 72(1): 222 - 232.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Tomic', F. Van Goor, M.-L. He, D. Zivadinovic, and S. S. Stojilkovic
Ca2+-Mobilizing Endothelin-A Receptors Inhibit Voltage-Gated Ca2+ Influx through Gi/o Signaling Pathway in Pituitary Lactotrophs
Mol. Pharmacol., June 1, 2002; 61(6): 1329 - 1339.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. S. Kostic, M. Tomic', S. A. Andric, and S. S. Stojilkovic
Calcium-independent and cAMP-dependent Modulation of Soluble Guanylyl Cyclase Activity by G Protein-coupled Receptors in Pituitary Cells
J. Biol. Chem., May 3, 2002; 277(19): 16412 - 16418.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Zivadinovic, M. Tomic, D. Yuan, and S. S. Stojilkovic
Cell-Type Specific Messenger Functions of Extracellular Calcium in the Anterior Pituitary
Endocrinology, February 1, 2002; 143(2): 445 - 455.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
F. Van Goor, Y.-X. Li, and S. S. Stojilkovic
Paradoxical Role of Large-Conductance Calcium-Activated K+ (BK) Channels in Controlling Action Potential-Driven Ca2+ Entry in Anterior Pituitary Cells
J. Neurosci., August 15, 2001; 21(16): 5902 - 5915.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
F. Van Goor, D. Zivadinovic, and S. S. Stojilkovic
Differential Expression of Ionic Channels in Rat Anterior Pituitary Cells
Mol. Endocrinol., July 1, 2001; 15(7): 1222 - 1236.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Van Goor, D. Zivadinovic, A. J. Martinez-Fuentes, and S. S. Stojilkovic
Dependence of Pituitary Hormone Secretion on the Pattern of Spontaneus Voltage-gated Calcium Influx. CELL TYPE-SPECIFIC ACTION POTENTIAL SECRETION COUPLING
J. Biol. Chem., August 31, 2001; 276(36): 33840 - 33846.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow